微信公众号
证券之星APP
| 报告期 | 净资产收益率 | 同比 | 环比 | 行业排名 | 行业均值 | 行业龙头股 | 龙头股该指标值 | 查看 |
|---|---|---|---|---|---|---|---|---|
| 2024-09-30 | 10.11% | 12.71% | 71.36% | 26/160 | 4.14% | 百利天恒 | 186.1% | 行业排名> |
| 2024-06-30 | 5.9% | 6.88% | 92.81% | 30/160 | 2.6% | 百利天恒 | 186.89% | 行业排名> |
| 2024-03-31 | 3.06% | 5.52% | -69.52% | 30/160 | 2.3% | 百利天恒 | 188.56% | 行业排名> |
| 2023-12-31 | 10.04% | -18.04% | 11.93% | 32/160 | -0.96% | 小方制药 | 41.8% | 行业排名> |
| 2023-09-30 | 8.97% | -5.38% | 62.5% | 30/160 | 2.37% | 拓新药业 | 20.51% | 行业排名> |
| 2023-06-30 | 5.52% | -2.13% | 90.34% | 34/160 | 1.51% | 拓新药业 | 19.87% | 行业排名> |
| 2023-03-31 | 2.9% | 1.75% | -76.33% | 36/160 | 1.38% | 拓新药业 | 19.91% | 行业排名> |
| 2022-12-31 | 12.25% | 1.58% | 29.22% | 28/160 | 0.8% | 小方制药 | 55.57% | 行业排名> |
| 2022-09-30 | 9.48% | -10.73% | 68.09% | 34/160 | 2.89% | 福元医药 | 25.41% | 行业排名> |
| 2022-06-30 | 5.64% | -0.53% | 97.89% | 40/160 | 2.24% | 小方制药 | 34.81% | 行业排名> |
| 2022-03-31 | 2.85% | -14.67% | -76.37% | 43/160 | 1.61% | 退市金泰 | 10.74% | 行业排名> |
| 2021-12-31 | 12.06% | 1.52% | 13.56% | 34/160 | 0.94% | 人福医药 | 6.82% | 行业排名> |
| 2021-09-30 | 10.62% | -3.37% | 87.3% | 29/160 | 4.53% | 小方制药 | 71.99% | 行业排名> |
| 2021-06-30 | 5.67% | 5.19% | 69.76% | 46/160 | 2.99% | 汇宇制药 | 39.25% | 行业排名> |
| 2021-03-31 | 3.34% | 27% | -71.89% | 36/160 | 2.52% | 汇宇制药 | 28.14% | 行业排名> |
| 2020-12-31 | 11.88% | 1.89% | 8.1% | 43/160 | 3.74% | 哈三联 | 27.17% | 行业排名> |
| 2020-09-30 | 10.99% | -18.71% | 103.9% | 34/160 | 3.22% | 汇宇制药 | 55.94% | 行业排名> |
| 2020-06-30 | 5.39% | -21.31% | 104.94% | 49/160 | 4.24% | 河化股份 | 45.32% | 行业排名> |
| 2020-03-31 | 2.63% | -28.34% | -77.44% | 39/160 | 2.24% | 汇宇制药 | 31.9% | 行业排名> |
| 2019-12-31 | 11.66% | 39.47% | -13.76% | 46/160 | 2.78% | 誉衡药业 | 35.56% | 行业排名> |
| 2019-09-30 | 13.52% | 51.23% | 97.37% | 16/160 | 7.61% | 奥赛康 | 35% | 行业排名> |
| 2019-06-30 | 6.85% | 37.27% | 86.65% | 32/160 | 5.05% | 奥赛康 | 28.15% | 行业排名> |
| 2019-03-31 | 3.67% | 65.32% | -56.1% | 25/160 | 2.46% | 宏源药业 | 21.91% | 行业排名> |
| 2018-12-31 | 8.36% | 476.55% | -6.49% | 61/160 | 7.09% | 奥赛康 | 9.7% | 行业排名> |
| 2018-09-30 | 8.94% | -6.49% | 79.16% | 32/160 | 7.26% | 奥赛康 | 40.69% | 行业排名> |
| 2018-06-30 | 4.99% | -20.03% | 124.77% | 42/160 | 4.65% | 信立泰 | 25.93% | 行业排名> |
| 2018-03-31 | 2.22% | -27.21% | 53.1% | 48/160 | 2.55% | 昂利康 | 15.91% | 行业排名> |
| 2017-12-31 | 1.45% | -82.68% | -84.83% | 111/160 | 9.66% | 奥赛康 | 12.08% | 行业排名> |
| 2017-09-30 | 9.56% | 9.51% | 53.21% | 35/160 | 8.31% | 一品红 | 31.62% | 行业排名> |
| 2017-06-30 | 6.24% | 11.43% | 104.59% | 33/160 | 5.59% | 丽珠集团 | 49.43% | 行业排名> |
| 2017-03-31 | 3.05% | 13.38% | -63.56% | 26/160 | 2.1% | 河化股份 | 54.24% | 行业排名> |
| 2016-12-31 | 8.37% | -14.33% | -4.12% | 65/160 | 6.33% | 华东医药 | 7.2% | 行业排名> |
| 2016-09-30 | 8.73% | -11.55% | 55.89% | 30/160 | 5.61% | 南新制药 | 81.7% | 行业排名> |
| 2016-06-30 | 5.6% | -9.82% | 108.18% | 38/160 | 3.53% | 德展健康 | 29.5% | 行业排名> |
| 2016-03-31 | 2.69% | -6.92% | -72.47% | 30/160 | 2.65% | 贝达药业 | 16.78% | 行业排名> |
| 2015-12-31 | 9.77% | 2.09% | -1.01% | 51/160 | 11.35% | 河化股份 | 19.29% | 行业排名> |
| 2015-09-30 | 9.87% | 8.22% | 58.94% | 28/160 | 7.22% | 一品红 | 58.17% | 行业排名> |
| 2015-06-30 | 6.21% | -12.04% | 114.88% | 30/160 | 4.9% | 华东医药 | 36.97% | 行业排名> |
| 2015-03-31 | 2.89% | -2.69% | -69.8% | 31/160 | 2.41% | 华东医药 | 26.63% | 行业排名> |